IMPUTE is developing a digital therapeutics application that uses AI technology combined with Applied Behavior Analysis (ABA) to treat and alleviate symptoms of autism spectrum disorder (ASD). The company was founded by Dr. Mayank Singh and is based in Tokyo. IMPUTE plans to use behavioral data and AI-driven interventions within its app to deliver or augment established ABA approaches. The firm has begun clinical research on its autism therapy app at the National Center for Child Health and Development, enrolling children aged roughly 18 months to 6 years who are diagnosed with or suspected of having ASD and are consulting with a counseling agency. IMPUTE recently completed a pre‑Series A from TEP (Tx Entrepreneurs Partners), Arco Partners and other angel investors. Most recently it announced a Series A investment to accelerate product development and fund clinical trials.

Total raised

$1M

Funding rounds

1

Latest round

Series A

Latest activity

Jan 2022